Although there was no statistical correlation between the magnitude of change in circulating CD19+CD24−CD38hi plasmablasts/plasma cells and the change in the IgG4-RD RI, this may emerge when more patients are studied. The gene discussed is CD19; the disease is immunoglobulin G4-related sclerosing disease.